Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers

Biological Psychiatry

Volumn 51, Issue 5, 2002, Pages 400-406

  Umbricht, Daniel ^a   Koller, Rene ^a   Vollenweider, Franz X ^a   Schmid, Liselotte ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

5 HT2A receptor; Ketamine; Mismatch negativity; NMDA receptor; Psilocybin; Psychosis

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PSILOCYBINE; SEROTONIN 2A AGONIST;

ADULT; ARTICLE; CALCULATION; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; MISMATCH NEGATIVITY; NEUROTRANSMISSION; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; CEREBRAL CORTEX; CONTINGENT NEGATIVE VARIATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; PSILOCYBINE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN;

EID: 0036501435     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01242-2     Document Type: Article

References (39)

1. Serotonin and hallucinogens
2. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release
3. Serotonin model of schizophrenia: Emerging role of glutamate mechanisms
4. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D- aspartate receptor antagonists
5. Aussergewöhnliche bewusstseinszustände - Ihre gemeinsame struktur und messung
6. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
7. Brain potential evidence for an auditory sensory memory deficit in schizophrenia
8. Excitatory Amino Acid Neurotransmission
9. Effects of signal probability on sensory evoked potentials in cats
10. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans
11. Psychedelic-like phenomena are common features of acute endogenous psychotic states: Results of an empirical study
12. Determination of psilocin and 4-hydroxyindole-3 acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man
13. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia
14. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia
15. Detection of stimulus deviance within primate primary auditory cortex: Intracortical mechanisms of mismatch negativity (MMN) generation
16. Recent advances in the phencyclidine model of schizophrenia
17. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin
18. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia
19. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
20. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
21. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
22. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
23. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function
24. The mismatch negativity: A powerful tool for cognitive neuroscience
25. Differentiation of negative event-related potentials in an auditory discrimination task
26. Glutamate receptor dysfunction and schizophrenia
27. Brief psychiatric rating scale
28. Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors
29. Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrous oxide
30. The mismatch negativity of event-related potentials as a probe of transient auditory memory: A review
31. Ketamine reduces the neuromagnetic mismatch reaction
32. N-methyl-D-aspartate enhancement of phasic responses in primate neocortex
33. Effects of clozapine on auditory event-related potentials in schizophrenia
34. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia
35. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)
36. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
37. 11C]raclopride
38. Effects of (S)-ketamine on striatal dopamine: A [11C]raclopride PET study of a model psychosis in humans
39. Anchoring the Brief Psychiatric Rating Scale; an aid to improve reliability